Financial reports
10-K
2022 FY
Annual report
29 Mar 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
5 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
10-K
2021 FY
Annual report
3 Mar 22
10-Q
2021 Q3
Quarterly report
5 Nov 21
10-Q
2021 Q2
Quarterly report
9 Aug 21
10-Q
2021 Q1
Quarterly report
6 May 21
10-K/A
2020 FY
Annual report (amended)
30 Apr 21
10-K
2020 FY
Annual report
11 Mar 21
Current reports
8-K
Termination of a Material Definitive Agreement
27 Apr 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6 Apr 23
8-K
Other Events
21 Mar 23
8-K
Chembio Announces Letter to Stockholders Regarding Tender Offer
15 Mar 23
8-K
Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System
24 Feb 23
8-K
Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement
31 Jan 23
8-K
Chembio Diagnostics Reports Third Quarter 2022 Financial Results
3 Nov 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4 Oct 22
8-K
Other Events
7 Sep 22
8-K
Chembio Diagnostics Reports Second Quarter 2022 Financial Results
4 Aug 22
Registration and prospectus
15-12G
Securities registration termination
8 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
27 Apr 23
S-8 POS
Registration of securities for employees (post-effective amendment)
27 Apr 23
S-8 POS
Registration of securities for employees (post-effective amendment)
27 Apr 23
S-8 POS
Registration of securities for employees (post-effective amendment)
27 Apr 23
S-8 POS
Registration of securities for employees (post-effective amendment)
27 Apr 23
S-8 POS
Registration of securities for employees (post-effective amendment)
27 Apr 23
POS AM
Prospectus update (post-effective amendment)
27 Apr 23
POS AM
Prospectus update (post-effective amendment)
27 Apr 23
POS AM
Prospectus update (post-effective amendment)
27 Apr 23
Proxies
DEF 14A
Definitive proxy
11 Apr 22
DEFA14A
Additional proxy soliciting materials
13 May 21
DEF 14A
Definitive proxy
13 May 21
DEFA14A
Additional proxy soliciting materials
8 Jul 20
DEFA14A
Additional proxy soliciting materials
8 Jul 20
DEF 14A
Definitive proxy
16 Jun 20
PRE 14A
Preliminary proxy
29 May 20
DEFA14A
Additional proxy soliciting materials
8 May 19
DEFR14A
Revised proxy
1 May 19
DEF 14A
Definitive proxy
30 Apr 19
Other
EFFECT
Notice of effectiveness
3 May 23
EFFECT
Notice of effectiveness
3 May 23
EFFECT
Notice of effectiveness
3 May 23
EFFECT
Notice of effectiveness
3 May 23
EFFECT
Notice of effectiveness
3 May 23
EFFECT
Notice of effectiveness
7 May 21
CORRESP
Correspondence with SEC
3 May 21
UPLOAD
Letter from SEC
19 Mar 21
CORRESP
Correspondence with SEC
12 Mar 21
UPLOAD
Letter from SEC
17 Jun 20
Ownership
SC 13D/A
PERCEPTIVE ADVISORS LLC
4 May 23
4
Paul Angelico
2 May 23
4
David Acheson
1 May 23
4
RICHARD EBERLY
1 May 23
4
Lawrence J. Steenvoorden
1 May 23
4
David William Bespalko
1 May 23
4
John Gary Potthoff
1 May 23
4
Javan Esfandiari
1 May 23
4
Leslie Teso-Lichtman
1 May 23
4
Charles Caso
1 May 23